Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Free Report) announced a dividend on Wednesday, October 18th, NASDAQ reports. Shareholders of record on Monday, October 16th will be paid a dividend of 1.5118 per share on Friday, October 20th. The ex-dividend date is Friday, October 20th. Talaris Therapeutics Price Performance Shares of Talaris Therapeutics stock opened at […]
Tourmaline will be focused on advancing TOUR006, its differentiated anti-IL-6 antibody, to treat thyroid eye disease (TED), atherosclerotic cardiovascular.
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.